ASX Announcement Quarterly Report – September 2026 Perth, Australia; 22 October 2026: Regenerative medicine company Orthocell Limited (ASX: OCC, “Orthocell” or the “Company”) is pleased to release its Quarterly Report for the quarter ended 30 September 2026. Key highlights for the quarter...
Quarterly Activity Report & Appendix 4C
Filed with ASX ·
6ix is reading this filing.
In the deck
Story so far
Earlier from Orthocell
- Remplir Shows Excellent Early Prostatectomy Results
- Orthocell Achieves First Remplir Sales in Thailand
- Q4 FY26 ASX Investor Presentation
- Orthocell Appoints Thailand Distributor for Remplir
- Remplir™: Australian Nerve Repair Device Supports Victims of War in Ukraine
Later from Orthocell
All Orthocell news releasesFollow Orthocell into a list and get an email when it puts out news.
Follow Orthocell